IPO registrations (S-1, F-1) · Registrants
Brainsway Ltd.
- SEC CIK
- 1505065 · filings on EDGAR ↗
- Registration
- Form F-1, first filed 2011-04-11, last 2019-04-10; 2 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2019-04-17; declared effective 2019-04-16; withdrawal requested 2011-06-14
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- L3
- Business address
- 16 HARTUM STREET RAD TOWER, 14TH FLOOR, Har HaHotzvim, Jerusalem, L3 9777516
- Ticker
- BWAY, BRSYF (Nasdaq, OTC)
- EDGAR entity type
- other
- Insiders and CEO pay
- Brainsway Ltd. on the corporate pages
Offering terms
- Final price
- $11.00 per ADS (424B4 filed 2019-04-17, an initial public offering)
- Shares sold
- 2,500,000
- Gross proceeds
- $27,500,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol BWAY
- Lead underwriters
- Cantor Fitzgerald
- Syndicate
- Raymond James; Oppenheimer; Ladenburg Thalmann
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Brainsway Ltd. EXACT (CIK (EXACT))
- SEC filer: Brainsway Ltd. EXACT (CIK (EXACT))
- Person page: Jonathan K Shulkin Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 13
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2011-04-11 | F-1 | F-1 (foreign registration) | Brainsway Ltd. | 0001178913-11-001085 ↗ |
| 2011-04-28 | F-1/A | F-1/A (amendment) | Brainsway Ltd. | 0001178913-11-001216 ↗ |
| 2011-05-26 | F-1/A | F-1/A (amendment) | Brainsway Ltd. | 0001178913-11-001575 ↗ |
| 2011-05-31 | F-1/A | F-1/A (amendment) | Brainsway Ltd. | 0001178913-11-001614 ↗ |
| 2011-06-14 | RW | RW (withdrawal request) | Brainsway Ltd. | 0001178913-11-001731 ↗ |
| 2012-09-14 | RW | RW (withdrawal request) | Brainsway Ltd. | 0001178913-12-002653 ↗ |
| 2019-01-14 | F-1 | F-1 (foreign registration) | Brainsway Ltd. | 0001047469-19-000119 ↗ |
| 2019-03-26 | F-1/A | F-1/A (amendment) | Brainsway Ltd. | 0001047469-19-001614 ↗ |
| 2019-04-03 | F-1/A | F-1/A (amendment) | Brainsway Ltd. | 0001047469-19-001901 ↗ |
| 2019-04-10 | F-1/A | F-1/A (amendment) | Brainsway Ltd. | 0001047469-19-002118 ↗ |
| 2019-04-16 | EFFECT | EFFECT (declared effective) | Brainsway Ltd. | 9999999995-19-000729 ↗ |
| 2019-04-17 | 424B4 | 424B4 (final prospectus) | Brainsway Ltd. | 0001047469-19-002315 ↗ |
| 2020-10-16 | EFFECT | EFFECT (declared effective) | Brainsway Ltd. | 9999999995-20-002886 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-04-10 | F-1/A | registration statement | 2,500,000 | - | Nasdaq BWAY | 4 | primary document; shares headline, cover names 4 | document ↗ | ||
| 2019-04-17 | 424B4 | final prospectus | $11.00 | 2,500,000 | $27,500,000 | Nasdaq BWAY | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Boehm Amiram | Director | 1 | 2026 | ||
| Hanlon Colleen | Officer | VP of Medical Affairs | 1 | 2026 | |
| Levy Hadar | Officer | Chief Executive Officer | 1 | 2026 | |
| Lushi Avner | Director | 1 | 2026 | ||
| Marom Ido | Officer | Chief Financial Officer | 1 | 2026 | |
| Mitrany Rayten Michal Ety | Director | 3 | 2026 | ||
| Moiseyev Gilad | Officer | Chief Technology Officer | 2 | 2026 | |
| Roth Yiftach | Officer | Chief Scientist | 2 | 2026 | |
| Rozenfeld Naomi | Officer | Chief Marketing Officer | 1 | 2026 | |
| SARID KAREN | Director | 1 | 2026 | ||
| Shulkin Jonathan K | Director | 1 | 2026 | person page Fuzzy | |
| Zacut David | Director | 1 | 2026 | ||
| Zangen Abraham | Director | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-10-15 | Brainsway Ltd. | Biotechnology | $20,000,009 | $20,000,009 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Brainsway Ltd. | Form D private offerings | CIK (EXACT) | |
| SEC filer | Brainsway Ltd. | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | Jonathan K Shulkin | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, L3 first:
- OWC Pharmaceutical Research Corp. L3
- MEDISAFE 1 TECHNOLOGIES CORP L3
- ActiVein, Inc. L3
- D. MEDICAL INDUSTRIES LTD. L3
- SAFECODE DRUG TECHNOLOGIES CORP. L3
- MAZOR ROBOTICS LTD. L3
- BioLight Life Sciences Ltd. L3
- INFEED MEDICA CORP L3
- PolyPid Ltd. L3
- Itamar Medical Ltd. L3
In other datasets, the same topic (Technology) in L3:
- Form D issuer: Advanced Memtech Ltd (Form D private offerings)
Interests: Surgical & Medical Instruments & Apparatus · Technology